inhibitory
[용어속성] Action
Mechanisms of Immunothrombosis by SARS-CoV-2
Review
[키워드] affecting
appear
case-control studies
Cell
cells
characterized
clinical trials
Contact
COVID-19
Damage-associated molecular patterns
DNA
endothelial cells
endothelial damage
extracellular DNA
extracellular RNA
Factor
Histones
immunothrombosis
Inflammation
inhibitory
mechanism
Neutrophil extracellular traps
observational study
pathogen
pathogen-associated molecular patterns
Patient
Platelets
Regulatory
RNA
SARS-CoV-2
Stage
tissue
translational
[DOI] 10.3390/biom11111550 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/biom11111550 PMC 바로가기 [Article Type] Review
Virtual Screening on Marine Natural Products for Discovering TMPRSS2 Inhibitors
Chemistry
[키워드] ACE2
ADME
angiotensin-converting enzyme 2
applied
blocked
blockers
camostat
CAS
Cell
cellular
compounds
COVID-19
distribution
docking
exhibited
homology
homology model
inhibit
inhibitor
inhibitory
inhibitory activity
inhibitory effect
introduced
metabolism
MNP
molecular docking
Molecular modeling
natural
performed
pharmacokinetic
priming
product
SARS-CoV-2
SARS-CoV-2 entry
Screening
shown
Spike protein
three-dimensional structure
TMPRSS2
transmembrane serine protease
Virtual screening
virus
were used
[DOI] 10.3389/fchem.2021.722633 PMC 바로가기 [Article Type] Chemistry
[DOI] 10.3389/fchem.2021.722633 PMC 바로가기 [Article Type] Chemistry
Plant Alkaloids Inhibit Membrane Fusion Mediated by Calcium and Fragments of MERS-CoV and SARS-CoV/SARS-CoV-2 Fusion Peptides
Article
[키워드] alkaloid
alkaloids
alteration
antiviral action
antiviral therapy
calcium
cholesterol
composed
Compound
concentrations
coronavirus
COVID-19
decrease
demonstrated
Effect
effective
Efficiency
fluorescence microscopy
fragment
fusion
fusion peptide
greater
in vitro
indicated
inhibit
inhibitory
investigated
knowledge
Lipid
Mediated
membrane
membrane fusion
MERS-CoV
non-toxic
Novel coronavirus
pandemic
peptides
Phosphatidylcholine
physical
piperine
plant
Prevent
progeny
reduce
SARS-CoV2
scattering
shown
significant changes in
significantly
suppress
tested
Vero Cell
Vesicle
viral fusion inhibitor
[DOI] 10.3390/biomedicines9101434 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/biomedicines9101434 PMC 바로가기 [Article Type] Article
Impaired function and delayed regeneration of dendritic cells in COVID-19
코로나19에서 손상된 수지상 세포의 기능 장애 및 재생 지연
Clinical Trial
[키워드] accompanied
activated
acute illness
acute phase
adaptive
Adaptive immune response
adaptive immune responses
alteration
analyzed
antibody
antibody-secreting cells
antiviral immunity
Blood
CD14
CD14+ cell
CD14+ cells
CD163
CD4
CD86
Cell
cells
circulating
classical monocyte
classical monocytes
Clinical management
consequence
contribute
correlated
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 severity
DCs
dendritic cell
dendritic cells
Depletion
disease
disease severity
downregulation
dysregulated
dysregulated innate immune response
expansion
follicular
Frequency
functional
healthy controls
helper cells
HLADR
hospitalized COVID-19 patient
Host immune response
identify
immune responses
immunopathology
Impaired
impairment
Increased
Inflammatory response
Inflammatory responses
inhibitory
innate immune response
long-lasting
manifestation
Mild
modulation
monocyte
monocyte subsets
Monocytes
naïve
Patient
PD-L1
persistent
recognize
reduced
reduction
regeneration
SARS-COV-2 infection
Secondary infection
secondary infections
severe disease
stimulate
subpopulation
subset
susceptibility
systemic inflammation
T cell
T cells
T follicular helper cells
the disease
therapy
these cell
These cells
Trigger
upregulation
Viral
viral infection
viral infections
[DOI] 10.1371/journal.ppat.1009742 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1371/journal.ppat.1009742 PMC 바로가기 [Article Type] Clinical Trial
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
mRNA-1273은 비인간 영장류의 SARS-CoV-2 베타 감염으로부터 보호합니다
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
airway
Antibody neutralization
Antibody titers
B.1.351
B.1.617.2
Bronchoalveolar lavage
coronavirus
Critical
dose
groups
immunization
Infection
inhibitory
live SARS-CoV-2
Moderna
mRNA
mRNA-1273
mRNA-1273 vaccine
nasal swab
nasal swabs
neutralization
Neutralizing antibody titer
neutralizing response
PROTECT
reduction
reduction in
Replication
respiratory
RNA
SARS-CoV-2
serum dilution
severe acute respiratory syndrome Coronavirus
single dose
These data
two-dose regimen
undetectable
Vaccine
variant
variants of concern
Viral
[DOI] 10.1038/s41590-021-01021-0 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41590-021-01021-0 PMC 바로가기 [Article Type] Article
Cyanobacterial metabolites as promising drug leads against the M pro and PL pro of SARS-CoV-2: an in silico analysis
유망한 약물로서 시아 노 박테리아 대사 산물은 SARS-COV-2의 M Pro 및 PL PRO에 대한 이끌어 낸다 : AN Silico Analysis
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
Analysis
antiviral drug
antiviral drugs
approach
binding energy
binding pocket
carrageenan
causative agent
Compound
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
cryptophycin
cyanobacterial metabolites
cylindrospermopsin
deoxycylindrospermopsin
drug-likeness
effective
effort
exhibited
facilitate
followed by
foundation
in silico
in silico analysis
in vitro
in vivo
inhibitor
inhibitory
lack
M pro
metabolite
metabolites
MM-PBSA
molecular
molecular docking
molecular dynamics
Molecular dynamics simulation
molecular dynamics simulations
pandemic
Papain
Papain-like protease
Pathologies
Physicochemical properties
physicochemical property
polyprotein
present
protease
Proteases
Research
research finding
respiratory
robust
SARS-CoV-2
SARS-CoV-2 protease
the SARS-CoV-2
Toxicity
Treatment
Viral
viral replication
were assessed
[DOI] 10.1080/07391102.2020.1794972 PMC 바로가기 [Article Type] Article
[DOI] 10.1080/07391102.2020.1794972 PMC 바로가기 [Article Type] Article
Theoretical and experimental study of interaction of macroheterocyclic compounds with ORF3a of SARS-CoV-2
Article
[키워드] assumption
bind
caused
Chlorin
combating
Compound
Computational models
coronavirus
country
creating
disease
docking
drug
Drug development
Fluorescence spectroscopy
Health
identify
in silico
include
Infectious disease
inhibitory
Interaction
Ligand
molecular docking
ORF3a
pandemic
Pathogenesis
performed
Porphyrin
porphyrins
Protein function predictions
SARS-CoV-2
SARS-CoV2
Spectrophotometry
Viral protein
virucidal
was used
[DOI] 10.1038/s41598-021-99072-8 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-99072-8 PMC 바로가기 [Article Type] Article
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients
Research Article
[키워드] 95% CI
95% confidence interval
acute phase
acute respiratory syndrome
administration
age
anti-SARS-CoV-2 antibody
antibodies
antibody
Characteristics
China
collected
conducted
convalescent COVID-19 patient
Convalescent patients
coronavirus
coronavirus disease
COVID-19
COVID-19 convalescent patient
COVID-19 patient
Dilution
discharge
discharged
disease severity
enrolled
Evidence
Factor
Follow-up
follow-up period
follow-up time
geometric mean titer
GMT
hospital
IgG
IgM
IgM/IgG
immune response
inhibitory
interquartile range
Jiangsu
Kinetics
male
median
Month
natural infection
Neutralizing activity
neutralizing antibody
Onset
participant
Patient
patients
persistence
plasma sample
produced
SARS-CoV-2
serological
seropositive
serum sample
severity
significantly higher
significantly lower
Specific
Standard deviation
symptom onset
tested
Vaccine
virus dynamics
with COVID-19
[DOI] 10.1128/Spectrum.00590-21 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1128/Spectrum.00590-21 PMC 바로가기 [Article Type] Research Article
Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19
Research article
Published on
Journal: Current Research in Pharmacology and Drug Discovery [Category] 신약개발, 치료법, 치료제,
Journal: Current Research in Pharmacology and Drug Discovery [Category] 신약개발, 치료법, 치료제,
[키워드] activity
acute respiratory syndrome
Analysis
Anti-COVID-19/Anti-SARS-CoV-2 drug
anti-SARS-CoV-2
antiviral action
binding
binding affinity
binding interaction
binding pocket
carried
caused
Computational molecular docking
Coronaviral-2 RNA-dependent RNA polymerase (RdRp)
coronavirus
coronavirus disease
COVID-19
COVID-19 cytokine storm
docking
drug candidate
Drug discovery
effective
evaluate
GS-441524
Health
hypothetical
inhibit
inhibitory
inhibitory activity
leflunomide
Ligand
lower binding energy
mechanism
metabolite
molecular docking
pandemic
Particle
pharmacological
problem
Protein
RdRP
Remdesivir/GS-441524
Replication
reported
Research
RNA
RNA-dependent RNA polymerase
SARS-CoV-2
SARS-CoV-2 strain
server
significantly
Support
Teriflunomide
the SARS-CoV-2
therapy
Treatment
Trial
undergo
viral replication
were used
[DOI] 10.1016/j.crphar.2021.100055 [Article Type] Research article
[DOI] 10.1016/j.crphar.2021.100055 [Article Type] Research article